Close Alert Banner
Skip to Content
Visit BORNOntario.caVisit BORN.ca
COVID-19: Information for PregnancyContact Us
FR

BORN Ontario Logo

Contact Us icon
  • What is Prenatal Screening?
    • What Do We Screen For?
    • Multiple Marker Screening (MMS)
    • Non-Invasive Prenatal Testing
    • Nuchal Translucency Ultrasound
    • Other Kinds of Screening
    • Less than 14 Weeks' Pregnant
    • 14-21 Weeks' Pregnant
    • Greater than 21 Weeks' Pregnant
    • For Twins or More Than Two Babies
    • COVID-19 and Prenatal Screening
  • Results and Next Steps
    • Multiple Marker Screening (MMS) Results
    • Non-invasive Prenatal Testing (NIPT) Results
    • Invasive Diagnostic Testing
  • Requisitions and Provider Tools
    • Multiple Marker Screening (MMS) Requisitions
    • Non-invasive Prenatal Testing (NIPT) Requisitions
    • Provider Tools
    • Facilities that offer Nuchal Translucency ultrasound
  • For Sonographers
    • NT Quality Assurance
    • Resources and Point of Care Tools
    • Facilities that offer Nuchal Translucency ultrasound
  • About Us
    • Contact Us
    • Careers
    • Events Calendar
    • Get Involved
    • Partners
    • PSO News
    • Subscribe to PSO updates
HomeWhat is Prenatal Screening?Non-Invasive Prenatal TestingNIPT Funding Criteria
  • Open new window to share this page via Facebook Facebook
  • Open new window to share this page via LinkedIn LinkedIn
  • Open new window to share this page via Twitter Twitter
  • Email this page Email

double helix

NIPT Funding Criteria

NIPT is available to all pregnant individuals in Ontario but will only be covered by Ontario Health Insurance Plan (OHIP) if one of the specific criteria is met at the time of blood draw.

For patients that do not meet the requirements, NIPT can be paid for out of pocket. Some personal health insurance plans cover the cost of NIPT. There are two laboratories that perform NIPT in Ontario: Dynacare and LifeLabs. The cost of their test for self-pay patients is between $500-$550, and the health care providers will need to complete the appropriate self-pay requisition (lab-specific) for testing. There are other commercial laboratories who provide this type of screening outside of Canada, however Prenatal Screening Ontario does not have any data capture or quality assurance role.

Important:  Temporary changes to OHIP-funding for NIPT are in effect , and these will be applicable from April 6, 2020 until June 30, 2021. 

OHIP will fund NIPT if:

Category I criteria (can be ordered by any physician or nurse practitioner for singletons and temporarily for twin pregnancies)

  • a positive prenatal screening result from multiple marker screening (MMS) for this pregnancy
  • the maternal age will be 40 years or older at the expected date of delivery
    • in the context of in vitro fertilization,  the maternal age is guided by the age at egg retrieval (whether own egg or donor egg)
  • the nuchal translucency (NT) measurement is ≥3.5mm
  • there is a personal history of a previous pregnancy or child with Trisomy 21, 18 or 13
  • exceptional funding due to COVID-19 pandemic for any twin pregnancy where either
    • NT ultrasound is unavailable OR
    • when the maternal age will be 35 years or older at the expected day of delivery. In the context of in vitro fertilization,  the maternal age is guided by the age at egg retrieval (whether own egg or donor egg)

If you meet one of these requirements, your health care provider can use the OHIP-funded requisition for testing. 

Please note that the requisitions have NOT been updated with the additional guidelines implemented due to the COVID-19 pandemic, since these changes are temporary. If your patient is eligible for OHIP-funded NIPT based on one of the temporary criteria, specify that on the MOH checklist section of the requisition. 

Category II criteria (must be ordered by a genetics or maternal-fetal medicine specialist for singletons and twin pregnancies)

  • there are findings on ultrasound which are associated with an increased chance for trisomy 21, trisomy 18 or trisomy 13
  • there is chance for a sex-linked genetic condition
  • the ultrasound shows findings suggestive of a sex chromosome difference
  • the ultrasound shows findings suggestive of a disorder of sex determination

If you meet one of these requirements, your health care provider can use the OHIP-funded requisition for testing.


Please note that in order for NIPT to be funded by OHIP, the pregnant person must meet the eligibility criteria at the time that the testing is performed. If none of the above funding criteria is met at the time of blood draw, the test is not medically necessary nor insured, and therefore reimbursement cannot be issued by the lab.

You can consider pursuing MMS (eFTS or MSS) as the first step before deciding to pay out-of-pocket for NIPT. A screen positive results from MMS prior to NIPT blood draw would allow for the NIPT to be funded by OHIP.

For additional information, the Health Insurance Act (HIA) and the Commitment to the Future of Medicare Act (CFMA) are available on the government website at www.e-laws.gov.on.ca. You may contact the CFMA program at 1-888-662-6613 or by email at protectpublichealthcare@ontario.ca if you have further questions or feel that you have been charged for a service that is insured.

 

  • What is Prenatal Screening?
    • What Do We Screen For?
      Toggle Section What Do We Screen For? Menu
      • Chromosomes
      • Trisomy 21 (Down syndrome)
      • Trisomy 18
      • Trisomy 13
      • Sex chromosome differences
    • Multiple Marker Screening (MMS)
      Toggle Section Multiple Marker Screening (MMS) Menu
      • Enhanced First Trimester Screening (eFTS)
      • Maternal Serum Screen (MSS)
    • Non-Invasive Prenatal Testing
      Toggle Section Non-Invasive Prenatal Testing Menu
      • NIPT Funding Criteria
    • Nuchal Translucency Ultrasound
      Toggle Section Nuchal Translucency Ultrasound Menu
      • Increased Nuchal Translucency
    • Other Kinds of Screening
    • Less than 14 Weeks' Pregnant
      Toggle Section Less than 14 Weeks' Pregnant Menu
      • Enhanced First Trimester Screening (eFTS)
      • Nuchal Translucency Ultrasound
        Toggle Section Nuchal Translucency Ultrasound Menu
        • Increased Nuchal Translucency
      • Non-invasive Prenatal Testing
    • 14-21 Weeks' Pregnant
      Toggle Section 14-21 Weeks' Pregnant Menu
      • Multiple Marker Screening (MMS)
      • Non-invasive Prenatal Testing
      • Detailed Anatomy Ultrasound
    • Greater than 21 Weeks' Pregnant
      Toggle Section Greater than 21 Weeks' Pregnant Menu
      • Non-invasive Prenatal Testing
      • Detailed Anatomy Ultrasound
    • For Twins or More Than Two Babies
    • COVID-19 and Prenatal Screening

Contact Us

Subscribe to this page

Prenatal Screening Ontario logo

BORN Ontario logo

Our Website

  • What is Prenatal Screening?
  • Results and Next Steps
  • Requisitions and Provider Tools
  • For Sonographers
  • About Us

Helpful Links

  • Contact Us
  • Sitemap
  • Website Feedback
  • View our Facebook Page
  • View our Twitter Page

Contact Us

Prenatal Screening Ontario 
CHEO Research Institute 
Centre for Practice-Changing Research Building 
401 Smyth Road 
Ottawa, ON K1H 8L1

Phone 613-737-2281

Toll Free 1-833-351-6490

Monday to Friday, 8:00 AM to 4:00 PM

Copyright © 2019 BORN Ontario

Designed by eSolutionsGroup

Close Old Browser Notification
Browser Compatibility Notification
It appears you are trying to access this site using an outdated browser. As a result, parts of the site may not function properly for you. We recommend updating your browser to its most recent version at your earliest convenience.